Parker Waichman LLP News and Press Releases

Safety 60/100Rated 60/100Source typeSpecialist communityIndependent sourcesstill being verifiedEvery claim links to the page it came from, and stronger sources rate higher. Full methodology →
↗ source

Law firm Parker Waichman LLP is filing lawsuits alleging that patients taking GLP-1 receptor agonist medications Ozempic and Wegovy developed NAION, an irreversible eye condition causing vision loss. The firm has filed multiple suits on behalf of residents of Georgia, California, Ohio, and Massachusetts. It also welcomed strengthened NAION safety guidance from Health Canada and Australia's TGA, and a client shared her vision-loss story with FOX Boston 25 News.

Related peptides

SemaglutideGLP-1 receptor agonistsGLP-1BINGNOTAGLP-1 MedicationsGLP-1 drugsGLP-1RGLP-1 receptor agonist drugsNADAHealth CanadaCanada
We summarize, we don't invent — every detail here traces to a real, linked source, and the badge reflects how trustworthy that source is. Read the original and decide for yourself.

Free: The Peptide Stack Cheat-Sheet

The most-used peptide combinations, what the research actually says, and where to buy — one page, one email.

No spam. Unsubscribe anytime.